Luisa Lina Villa

Epidemiology · 2001–2010

A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 39 citations into it
• Surgery — 12 citations into it

Whom Luisa Lina Villa trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. L. Koutsky

Who trusts Luisa Lina Villa overall

1. Who
2. K. Ault

Papers from Luisa Lina Villa's perspective

Ordered by how strongly the researchers Luisa Lina Villa trusts endorse each paper. Same corpus, a different order for every researcher.

1. HPV screening for cervical cancer in rural India. (New England Journal of Medicine)
2. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
3. Nonparametric Estimation from Incomplete Observations
4. iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns
5. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (New England Journal of Medicine)
6. Epidemiologic classification of human papillomavirus types associated with cervical cancer. (New England Journal of Medicine)
7. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. (The Lancet)
8. The causal relation between human papillomavirus and cervical cancer. (Journal of Clinical Pathology)
9. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. (Journal of the National Cancer Institute. Monographs)
10. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. (The Lancet)

Their papers

• Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010) — 638 citations
• Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) — 1,759 citations
• Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (2006) — 661 citations
• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up (2006) — 901 citations
• Chapter 5: Updating the natural history of HPV and anogenital cancer. (2006) — 603 citations
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. (2005) — 1,716 citations
• Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. (2001) — 623 citations